Phenotypic Differences of CD103+ Tissue-Resident Memory T Cells Associated with Various Cancers
Pathobiology · 2022 · 89 (2) · 116-126
DOI: 10.1159/000518972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathobiology, online erschienen am 30.09.2021. Verfasst von Hye Seon Park und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Memory T Cells, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background/Aims: The presence and clinical importance of tissue-resident memory T (TRM) cells have been recently described in association with various cancer types. However, the frequency and the traditional naïve–effector–memory phenotypic characteristics of TRM cells are largely unknown.
Methods
We analyzed single-cell populations of colorectal cancer (CC, n = 18), stomach cancer (SC, n = 13), renal cell carcinoma (RCC, n = 19), and breast cancer (BC, n = 16) by dissociation of tumor tissue with collagenase/hyaluronidase. We investigated populations of naïve, effector, and memory T and TRM cells by flow cytometry.
Results
Among CD8− cells, CC was associated with a significantly higher proportion of CD103+ T cells than other tumor types (p < 0.001). Among CD8+ cells, CC and SC were associated with higher CD103+ T-cell proportions than RCC and BC (p < 0.001). Significantly more CD8+ than CD8− cells expressed CD103 (p < 0.001). In association with SC, RCC, and BC, CD8+ T cells had a similar T-cell phenotype composition pattern: fewer effector T cells and more memory-type T cells among CD103+ cells compared with CD103− cells (p < 0.05). Tumors with higher proportion of CD103+ cells had no specific clinicopathologic characteristics than those with lower proportion of CD103+ cells.
Conclusion
TRM cell abundance and phenotypes varied among CC, SC, RCC, and BC. Further studies regarding the functional differences of TRM associated with various tumors are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
- Biomedical Sciences, Asan Medical Institute of Convergence Science and Technology (AMIST), University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
- Department of Pathology and Translational Genomics, Samsung Medical Center, Seoul, Republic of Korea.
Zitieren
APA
Park, H. S., Jeon, Y., Lee, H., Lee, H., Kim, Y. A., Park, I. A., Bang, W. S., Lee, M., Cho, Y. J., Kim, J., Gong, G., & Lee, H. J. (2022). Phenotypic Differences of CD103+ Tissue-Resident Memory T Cells Associated with Various Cancers. Pathobiology, 89(2), 116-126. https://doi.org/10.1159/000518972
Vancouver
Park HS, Jeon Y, Lee H, Lee H, Kim YA, Park IA, et al. Phenotypic Differences of CD103+ Tissue-Resident Memory T Cells Associated with Various Cancers. Pathobiology. 2022;89(2):116-126. doi:10.1159/000518972
BibTeX
@article{Park2022,
author = {Park, Hye Seon and Jeon, Yeonjin and Lee, Hyun and Lee, Heejae and Kim, Young-Ae and Park, In Ah and Bang, Won Seon and Lee, Miseon and Cho, Young Jin and Kim, Jihyeong and Gong, Gyungyub and Lee, Hee Jin},
title = {Phenotypic Differences of CD103+ Tissue-Resident Memory T Cells Associated with Various Cancers},
journal = {Pathobiology},
year = {2022},
volume = {89},
number = {2},
pages = {116--126},
doi = {10.1159/000518972}
}
EUVIMED